Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Alignment Healthcare
ALHC
$2.86B
| $24.2M | ﹤0.01% |
1,299,973
+539,494
| +71% | +$8.04M |
|
|
LX
2502
LexinFintech Holdings
LX
$242M
| $24.2M | ﹤0.01% |
2,397,896
-2,403,951
| -50% | -$20.1M |
|
2503
Scorpio Tankers
STNG
$3.83B
| $24.2M | ﹤0.01% |
643,355
+196,631
| +44% | +$8.81M |
|
2504
Cemex
CX
$16.3B
| $24.2M | ﹤0.01% |
4,307,794
-575,540
| -12% | -$3.48M |
|
2505
PagSeguro Digital
PAGS
$2.54B
| $24.2M | ﹤0.01% |
3,165,488
-99,026
| -3% | -$737K |
|
2506
ICF International
ICFI
$1.64B
| $24.1M | ﹤0.01% |
284,189
-24,120
| -8% | -$2.53M |
|
2507
Energizer
ENR
$1.5B
| $24.1M | ﹤0.01% |
806,571
+75,452
| +10% | +$2.42M |
|
2508
Protagonist Therapeutics
PTGX
$9.71B
| $24M | ﹤0.01% |
497,105
-43,210
| -8% | -$1.81M |
|
2509
Alliance Resource Partners
ARLP
$3.19B
| $24M | ﹤0.01% |
879,795
-136,830
| -13% | -$3.65M |
|
2510
BlackRock Resources & Commodities Strategy Trust
BCX
$962M
| $24M | ﹤0.01% |
2,569,976
-55,141
| -2% | -$502K |
|
2511
Twist Bioscience
TWST
$7.83B
| $24M | ﹤0.01% |
610,742
-288,427
| -32% | -$13M |
|
2512
Bloomin' Brands
BLMN
$944M
| $24M | ﹤0.01% |
3,341,773
+1,178,684
| +54% | +$12.5M |
|
2513
Hawkins
HWKN
$2.73B
| $24M | ﹤0.01% |
226,154
-33,040
| -13% | -$3.63M |
|
2514
Gibraltar Industries
ROCK
$1.45B
| $23.9M | ﹤0.01% |
408,251
+39,088
| +11% | +$2.43M |
|
2515
Maximus
MMS
$2.9B
| $23.9M | ﹤0.01% |
351,035
-151,261
| -30% | -$10.8M |
|
2516
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.7B
| $23.9M | ﹤0.01% |
721,394
+80,142
| +12% | +$2.64M |
|
2517
Capital Group International Equity ETF
CGIE
$2.46B
| $23.9M | ﹤0.01% |
815,949
+316,955
| +64% | +$9.23M |
|
2518
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $23.9M | ﹤0.01% |
1,076,399
-411,348
| -28% | -$8.47M |
|
2519
Stoke Therapeutics
STOK
$2.08B
| $23.9M | ﹤0.01% |
3,590,825
+153,581
| +4% | +$1.43M |
|
|
NCV
2520
Virtus Convertible & Income Fund
NCV
$391M
| $23.8M | ﹤0.01% |
1,842,362
+28,597
| +2% | +$394K |
|
2521
Perdoceo Education
PRDO
$1.97B
| $23.8M | ﹤0.01% |
945,158
+109,010
| +13% | +$2.9M |
|
2522
Vanguard ESG International Stock ETF
VSGX
$6.73B
| $23.8M | ﹤0.01% |
403,178
+1,148
| +0.3% | +$67.9K |
|
2523
Thor Industries
THO
$4.14B
| $23.7M | ﹤0.01% |
313,120
-66,013
| -17% | -$6.21M |
|
2524
TTM Technologies
TTMI
$13.7B
| $23.7M | ﹤0.01% |
1,153,695
+86,817
| +8% | +$2.1M |
|
2525
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.77B
| $23.6M | ﹤0.01% |
489,487
-43,061
| -8% | -$2.11M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.